Hemophilia is a sex-linked genetic disorder characterized by the deficiency or absence of one of the clotting proteins in plasma. Severe deficiency results in spontaneous bleeding into the joints and recurrent bleeding which, in turn, leads to hemophilic arthropathy, disability, and reduced quality of life. Currently, there is no known cure for hemophilia, so treatment goals include preventing bleeding, recognizing bleeding episodes, and providing prompt treatment and intervention to prevent complications.
- WEBCAST Breakthrough Therapies for Graft-Versus-Host-Disease
- Blood and Marrow Transplantation Reviews: Optimal Use of Stem Cell Mobilization in Patients with Hematologic Malignancies
- Blood and Marrow Transplantation Reviews: Examining Targeted Therapies for Hodgkin Lymphoma in the Post-Transplant Setting: Reason for Optimism
- WEBCAST Updates on Hematologic Malignancies: New Targeted Conditioning Regimens
- WEBCAST Utilizing CAR T Cells for Hematologic Malignancies in the Transplant Setting